Wegovy Maker Novo Nordisk Buys Embark Biotech to Boost Edge in Weight Loss TreatmentsInvestopedia • 08/30/23
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price CutsInvestors Business Daily • 08/29/23
How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity TreatmentInvestors Business Daily • 08/25/23
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO SaysForbes • 08/25/23
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks SoaringThe Motley Fool • 08/24/23
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors RicherThe Motley Fool • 08/24/23
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find ItThe Motley Fool • 08/23/23